A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.

NCT00577109 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was cancelled before patient enrollment

Conditions

Colorectal Cancer

Interventions

DRUG: bevacizumab [Avastin]
DRUG: Irinotecan
DRUG: Leucovorin
DRUG: 5 FU
DRUG: Cetuximab

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]